The tumor necrosis factor (TNF)/TNF receptor pathway affects the survival of cancer patients, and the potentially functional genetic variations of TNF/TNFR signaling pathway genes affect the survival rate of NSCLC patients (Guo et al., 2019). This evidence concerns the gene TNFRSF1A and non-small cell lung carcinoma.